Longevity Acquisition Corporation does not have significant operations. The company focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. Longevity Acquisition Corporation was founded in 2018 and is based in Shanghai, the People's Republic of China.
Research context
Longevity Acquisition Corporation appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Financial Services
- Industry
- Shell Companies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
Longevity Acquisition Corporation is currently in a long term uptrend where the price is trading 15.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Longevity Acquisition Corporation's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 69.0% to $-196K since the same quarter in the previous year.
Finally, its free cash flow grew by 66.9% to $-115K since the same quarter in the previous year.
Based on the above factors, Longevity Acquisition Corporation gets an overall score of 3/5.